Dr. Razouki is the current Chief Business Development Officer of Kuwait Life Sciences Company (KLSC) where he is responsible for identifying new business opportunities for all KLSC subsidiary companies as well as sourcing investments opportunities for KLSC corporate. Dr. Razouki is a regional thought leader within the Middle East life sciences industry having himself shifted from an excellence in clinical practice and research to the management and financing of healthcare systems.
A graduate of Columbia Business School, Dr. Razouki is the first ever Arab national to receive an MBA with a focus on Healthcare Management and Finance.
An Oral and Maxillofacial surgeon by training, Dr. Razouki has completed clinical rotations at the world’s top hospitals including New York Presbyterian Hospital of Columbia University Medical Center, Harlem Hospital, Cleveland University Hospital of Case Western Reserve University and Mass General Hospital of Harvard University.
In 2007, Dr. Razouki joined the world’s largest and oldest strategic consulting firms, Booz Allen Hamilton, which at the time was operating in over 100 countries across six continents with four billion dollars in revenue. Dr. Razouki was recruited from New York to the Dubai office, where he built the Middle East Healthcare Practice by leading a wide variety of projects across all five dimensions of the healthcare economy including investors, providers (of healthcare services), payors (insurance companies), suppliers (of medical equipment and pharmaceuticals) as well as regulators (governments). Regarding the latter, Dr. Razouki has the distinction of working with every single GCC Ministry of Health as well as both the Dubai Health Authority and the Health Authority of Abu Dhabi.
From 2011 to 2014, Dr. Razouki was the Chief Executive Officer of Kleos healthcare, a Middle East focused healthcare consulting and development company. Dr. Razouki led the turnaround of Kleos from a docile shell company into a well respected and profitable firm that is widely recognized as a regional authority on Middle East healthcare.
Dr. Razouki is also a former advisor to the Office of the Prime Minister of Kuwait and the Office of the Deputy Prime Minister for Economic Affairs, where he worked with senior government leaders on Healthcare, Education and Entrepreneurial reforms as part of Kuwait’s 100 billion Dollar Development Plan Dr. Razouki is also the former Chair of the Prime Minister’s Early Warning System Committee on Health, which was established as part of the Prime Minister’s Technical Advisory Office.
Kuwait Life Sciences Company
Kuwait Life Sciences Company focuses on healthcare innovative concepts and demanded services which have a clear unmet need. KLSC has been designed as an integrated healthcare company building unique projects and is considered one of the fewest venture capitalists in the Middle East that invests globally and operates regionally seeking to advance healthcare services and systems in the region. KLSC supports both public and private sectors to access emerging technologies, establish unique projects and adapt best practices prevailing in today’s healthcare field. KLSC operates in healthcare investment, medical technologies and training.